Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
Abstract: To compare serum disposition of flunixin meglumine after i.v. administration of a bolus to horses, donkeys, and mules. Methods: 3 clinically normal horses, 5 clinically normal donkeys, and 5 clinically normal mules. Methods: Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after i.v. administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight). Serum was analyzed in duplicate by the use of high-performance liquid chromatography for determination of flunixin meglumine concentrations. The serum concentration-time curve for each horse, donkey, and mule were analyzed separately to estimate noncompartmental pharmacokinetic variables Results: Mean (+/-SD) area under the curve for donkeys (646 +/- 148 minute x microg/ml) was significantly less than for horses (976 +/- 168 minute x microg/ml) or for mules (860 +/- 343 minute x microg/ml). Mean residence time for donkeys (54.6 +/- 7 minutes) was significantly less than for horses (110 +/- 24 minutes) or for mules (93 +/- 30 minutes). Mean total body clearance for donkeys (1.78 +/- 0.5 ml/kg/h) was significantly different from that for horses (1.14 +/- 0.18 ml/kg/h) but not from that for mules (1.4 +/- 0.5 ml/kg/h). Significant differences were not found between horses and mules for any pharmacokinetic variable. Conclusions: Significant differences exist with regard to serum disposition of flunixin meglumine in donkeys, compared with that for horses and mules. Consequently, flunixin meglumine dosing regimens used in horses may be inappropriate for use in donkeys.
Publication Date: 1999-11-24 PubMed ID: 10566824
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Animal Health
- Biological Half-Life
- Blood Analysis
- Clinical Pathology
- Clinical Study
- Comparative Study
- Drug
- Equine Health
- Flunixin Meglumine
- High-performance Liquid Chromatography (HPLC)
- Horses
- Intravenous Administration
- Mule
- Pharmacodynamics
- Pharmacokinetics
- Serum
- Species Comparison
- Veterinary Medicine
- Veterinary Research
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates the differences in how the drug flunixin meglumine is absorbed, distributed, metabolized, and excreted in donkeys, mules, and horses. It revealed critical variations in how donkeys process the drug, suggesting that dosage guidelines for horses may not be suitable for donkeys.
Study Design and Methodology
- The study involved a sample of 3 clinically normal horses, 5 clinically normal donkeys, and 5 clinically normal mules.
- Each animal was given a bolus administration of flunixin meglumine, an anti-inflammatory drug, intravenously at a dose of 1.1 mg/kg of body weight.
- Blood samples were collected before administering the drug and after specific time intervals (ranging from 5 minutes to 8 hours post-administration).
- The concentrations of flunixin meglumine in the serum were analyzed in duplicate using high-performance liquid chromatography.
- Noncompartmental pharmacokinetic variables were estimated separately for each horse, donkey, and mule from the serum concentration-time curve.
Research Findings
- The mean area under the curve (AUC), which represents overall drug exposure, for donkeys was significantly less than that of the horses and mules.
- The mean residence time, indicating how long the drug stays in the body, was also significantly shorter for donkeys compared to horses and mules.
- The mean total body clearance rate, representing how quickly the drug is removed from the body, was significantly different in donkeys compared to horses. However, no significant difference was observed between mules and donkeys.
- No significant differences were identified in any pharmacokinetic parameters between horses and mules. This suggests their bodies handle the drug in similar ways.
Conclusions
- There are significant differences in how the drug, flunixin meglumine, is processed by horses, donkeys, and mules.
- These differences are most pronounced between horses and donkeys, indicating that dosing regiments that work for horses may be inappropriate to use in donkeys.
Cite This Article
APA
Coakley M, Peck KE, Taylor TS, Matthews NS, Mealey KL.
(1999).
Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
Am J Vet Res, 60(11), 1441-1444.
Publication
Researcher Affiliations
- Texas Veterinary Medical Center, Texas A & M University, College Station 77843, USA.
MeSH Terms
- Animals
- Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal / blood
- Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
- Area Under Curve
- Clonixin / administration & dosage
- Clonixin / analogs & derivatives
- Clonixin / blood
- Clonixin / pharmacokinetics
- Equidae
- Female
- Horses
- Injections, Intravenous
- Male
- Metabolic Clearance Rate
- Species Specificity
- Time Factors
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists